Emergex Vaccines

Developer T-cell Vaccines for treating viral and bacterial infections

placeAbingdon, England, United Kingdom calendar_todayFounded 2016 groups19 employees language emergexvaccines.com

Registered entities

Innovation

14 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 1,121 times.

YearFilings
20171
20184
20198
20208
20218
20227
20235
20244
20253

Investor mix

15 investors on record; lead investors include Vickers Venture Partners.

Investor typeCountShare
Venture capital213%
Other / undisclosed1387%
Coming soon